Kawasaki Yukihiko, Maeda Ryo, Kanno Syuto, Suzuki Yuichi, Ohara Shinichiro, Suyama Kazuhide, Hosoya Mitsuaki
Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, Fukushima, 960-1295, Japan.
Clin Exp Nephrol. 2018 Aug;22(4):917-923. doi: 10.1007/s10157-017-1515-5. Epub 2017 Dec 2.
To clarify the long-term efficacy of multiple-drugs combination therapy (PWDM) and tonsillectomy pulse therapy (TPT) for pediatric IgA nephropathy (IgAN), we retrospectively evaluated the clinical and laboratory findings as well as the prognosis for IgAN patients treated with each treatment at long-term follow-up.
We collected data on 61 children who had been diagnosed with severe IgAN. The children were retrospectively divided into two groups. Group 1 consisted of 44 severe IgAN children treated with PWDM, and Group 2 consisted of 17 severe IgAN children treated with TPT. The clinical features, pathological findings, and prognosis were analyzed for both groups.
The mean urinary protein excretion, serum creatinine, IgA levels, MESTCG scores, and percentage of glomeruli showing crescents in both groups at the second renal biopsy were lower than those at the first renal biopsy. At the time of the second biopsy, the IgA level in Group 2 was lower than that in Group 1; however, there were no significant differences in the mean urinary protein excretion, frequency of hematuria, serum albumin, creatinine, or e-GFR between the two groups. At the most recent follow-up, there were no significant differences in prognosis between the groups.
Our study suggested that PWDM and TPT are effective in ameliorating urinary abnormalities and improving the long-term outcome of pediatric IgAN.
为阐明多药联合治疗(PWDM)和扁桃体切除脉冲治疗(TPT)对儿童IgA肾病(IgAN)的长期疗效,我们在长期随访中回顾性评估了接受每种治疗的IgAN患者的临床和实验室检查结果以及预后情况。
我们收集了61例被诊断为重度IgAN儿童的数据。这些儿童被回顾性分为两组。第1组由44例接受PWDM治疗的重度IgAN儿童组成,第2组由17例接受TPT治疗的重度IgAN儿童组成。对两组的临床特征、病理结果和预后进行了分析。
第二次肾活检时,两组的平均尿蛋白排泄量、血清肌酐、IgA水平、MESTCG评分以及出现新月体的肾小球百分比均低于第一次肾活检时。在第二次活检时,第2组的IgA水平低于第1组;然而,两组之间的平均尿蛋白排泄量、血尿频率、血清白蛋白、肌酐或估算肾小球滤过率(e-GFR)并无显著差异。在最近一次随访时,两组之间的预后无显著差异。
我们的研究表明,PWDM和TPT在改善儿童IgA肾病的尿液异常及长期预后方面是有效的。